...
首页> 外文期刊>Human vaccines & immunotherapeutics. >Formulation and immunological evaluation of a trivalent vaccine comprising emulsified submicron particles and inactivated virions of H5N1/EV71/JEV
【24h】

Formulation and immunological evaluation of a trivalent vaccine comprising emulsified submicron particles and inactivated virions of H5N1/EV71/JEV

机译:包含乳化亚微米颗粒和H5N1 / EV71 / JEV灭活病毒颗粒的三价疫苗的配制和免疫学评估

获取原文
获取原文并翻译 | 示例

摘要

Combination vaccines can reduce the number of injections and simplify the immunization schedule required to prevent different diseases. Here we assessed the immunogenicity in a mouse model of a vaccine composition comprising inactivated influenza viruses (H5N1/H1N1), enterovirus 71 (eV71), and/or Japanese encephalitis virus (JeV) and investigated whether the vaccine formulations can overcome the immunologic interference between the individual vaccine components. We demonstrated that the antigenic competition happens between H5N1/H1N1 or H5N1/eV71 inactivated virions when the vaccine combinations either formulated with alum suspensions or without adjuvant. In the presence of PeLc emulsified particles, eV71-specific immune responses before and after incorporating H5N1 virus into eV71 vaccine were detected of no significant difference; in addition, H5N1- and eV71-specific immune responses were found at the same level when H5N1/eV71/JeV consolidating into combination vaccine. emulsified vaccine formulation was represented as a potential tool that is found to reduce the number of injections required to prevent multiple infectious strains causing the same disease (H5N1/H1N1) and/or that protect against different diseases (H5N1/eV71). combination vaccines can also include a third component to protect against H5N1/eV71/JeV at the same time.
机译:组合疫苗可以减少注射次数并简化预防不同疾病所需的免疫程序。在这里,我们评估了包含灭活流感病毒(H5N1 / H1N1),肠病毒71(eV71)和/或日本脑炎病毒(JeV)的疫苗组合物在小鼠模型中的免疫原性,并研究了疫苗制剂是否可以克服两者之间的免疫干扰各个疫苗成分。我们证明了当用明矾悬浮液或不使用佐剂配制的疫苗组合时,抗原竞争发生在H5N1 / H1N1或H5N1 / eV71灭活病毒体之间。在存在PeLc乳化颗粒的情况下,检测到将H5N1病毒掺入eV71疫苗之前和之后eV71的特异性免疫反应均无显着性差异。此外,当H5N1 / eV71 / JeV整合为联合疫苗时,发现H5N1-和eV71特异性免疫反应处于相同水平。乳化疫苗制剂被认为是一种潜在的工具,可以减少预防引起同一疾病的多种传染株(H5N1 / H1N1)和/或预防不同疾病(H5N1 / eV71)所需的注射次数。组合疫苗还可以包含第三种成分,以同时预防H5N1 / eV71 / JeV。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号